Products for Research Use Only
RegisterLogin

CDK8/19-IN-2

CAT: 0931-T88262-01Size: 25 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T88262-01Size:25 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
3024381-54-9
Target
STAT, CDK
Related Pathways
Cell Cycle/Checkpoint, Stem Cells, JAK/STAT signaling
Bioactivity
CDK8/19-IN-2 (compound 12) is a potent inhibitor of cyclin-dependent kinases 8 and 19 (CDK8 and CDK19), exhibiting IC 50 values of 2.08 nM and 2.49 nM, respectively. This orally active compound is applicable in the research of acute myeloid leukemia (AML), breast cancer, and lymphoma.
Smiles
FC(F)C=1C(Br)=C(Br)C=C2C1N=C(N2C3CCOCC3)N4CCNCC4
Molecular Formula
C17H20Br2F2N4O
Molecular Weight
494.17
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

Related Products

CatalogName
T210596-01CDK8-IN-19
T22633-01CDK8/19-IN-51
T10739-01CDK8/19-IN-1
T204986-01CDK8/19-IN-3
T10740-01CDK8-IN-1
T204689-01CDK8-IN-17
T72048-01CDK8-IN-12
T62354-01CDK8-IN-7
T17305-01CDK8-IN-4
T61742-01CDK8-IN-11

Alternative Products

CatalogName
HY-158377CDK8/19-IN-2
HY-176282CDK8-IN-19
HY-111427-01CDK8/19-IN-1
HY-168846CDK8/19-IN-3
BUP21189-01CDK8/19-IN-51
A19857-1Anti-CDK8/19 Antibody
A19986-50CDK8/19-IN-1 50mg
A19986-25CDK8/19-IN-1 25mg
A19986-10CDK8/19-IN-1 10mg
A19986-1CDK8/19-IN-1 1mg

Popular Products